CANCER RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2022-11-09 124af5c7m81暂无昵称

请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？

138 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2024-04-28 147ce2ffm38(暂无昵称) 来自北京

编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平

150 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2024-08-16 ms3000001981169340 来自上海

偏重的研究方向：肿瘤研究
经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？

72 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2023-09-21 ms1000000959787142 来自天津

各位大佬们，这个杂志under editorial consideration 大概需要多久呀

157 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2023-06-18 ms2000000311873048 来自湖南省

审稿速度:1.0
偏重的研究方向：肿瘤
经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧

174 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2024-06-27 ms9000000416465180 来自广东省

偏重的研究方向：肿瘤基础研究;肿瘤
经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易

80 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2024-05-24 Anny Dian 来自密歇根

偏重的研究方向：肿瘤基础
经验分享：under editorial consideration 11天了，啥时候送审

137 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2024-05-27 ms2000000610574592 来自江苏省

投稿命中率:25.0
偏重的研究方向：circRNA;铁死亡;黑色素瘤
经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？

113 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2024-03-11 147c9105m80(暂无昵称) 来自江苏省

under editorial consideration 已经六天了一点动静没有是什么情况呀

124 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2099486, encodeId=29a3209948625, content=请问各位，最近投稿Cancer research，under review7天了，还没收到外审邮件，大家有遇到过这种情况吗？最长多久会收到外审邮件啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8a452506975, createdName=124af5c7m81暂无昵称, createdTime=Wed Nov 09 21:24:07 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2200930, encodeId=b9f122009302c, content=编辑们这是去响应学生运动了么，修回审稿结束后，under editorial consideration已经整2周，看来漂亮国最近有点不太平, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f57b5245693, createdName=147ce2ffm38(暂无昵称), createdTime=Sun Apr 28 19:41:01 CST 2024, time=2024-04-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2220618, encodeId=c72a22206189f, content=偏重的研究方向：肿瘤研究 经验分享：第一次修改是格式问题，然后积极配合调整后又重新提交了，现在一直停留initial pc好几天了，担忧，有相同情况的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=72, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=092b9098031, createdName=ms3000001981169340, createdTime=Fri Aug 16 19:04:35 CST 2024, time=2024-08-16, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2158905, encodeId=9aff2158905d4, content=各位大佬们，这个杂志under editorial consideration 大概需要多久呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7cb5620202, createdName=ms1000000959787142, createdTime=Thu Sep 21 14:00:28 CST 2023, time=2023-09-21, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2143534, encodeId=d49d21435346b, content=审稿速度:1.0 偏重的研究方向：肿瘤 经验分享：因为格式问题让修改，修改后又提交了，然后就停在Initial QC 2天了，这样不会被忘记吧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78186386984, createdName=ms2000000311873048, createdTime=Sun Jun 18 21:16:54 CST 2023, time=2023-06-18, status=1, ipAttribution=湖南省), GetPortalCommentsPageByObjectIdResponse(id=2211949, encodeId=59fb221194998, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：2023影响因子普遍下降的情况下还能涨个1分，挺不容易, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=66025731181, createdName=ms9000000416465180, createdTime=Thu Jun 27 16:07:42 CST 2024, time=2024-06-27, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2206431, encodeId=f30a220643116, content=偏重的研究方向：肿瘤基础 经验分享：under editorial consideration 11天了，啥时候送审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8de15464204, createdName=Anny Dian, createdTime=Fri May 24 15:21:32 CST 2024, time=2024-05-24, status=1, ipAttribution=密歇根), GetPortalCommentsPageByObjectIdResponse(id=2206844, encodeId=73632206844fa, content=投稿命中率:25.0 偏重的研究方向：circRNA;铁死亡;黑色素瘤 经验分享：请问大家initial QC等待4天了没用动静咋办，这是到编辑那边了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=68798414351, createdName=ms2000000610574592, createdTime=Mon May 27 14:11:38 CST 2024, time=2024-05-27, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2192521, encodeId=894f21925214a, content=under editorial consideration 已经六天了一点动静没有是什么情况呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=124, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47775244157, createdName=147c9105m80(暂无昵称), createdTime=Mon Mar 11 12:57:36 CST 2024, time=2024-03-11, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2139835, encodeId=0ab721398353a, content=偏重的研究方向：肿瘤基础研究;肿瘤 经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca15460308, createdName=ms3000001338909804, createdTime=Tue May 30 07:52:31 CST 2023, time=2023-05-30, status=1, ipAttribution=湖北省)]

2023-05-30 ms3000001338909804 来自湖北省

偏重的研究方向：肿瘤基础研究;肿瘤
经验分享：审稿好慢，under editorial consideration已经五天了，这是编辑还没看吗？

162 5

展开5条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务